References
- Andres H.H., Vogel R.S., Tarr G.E., Johnson L., Weber W.W. Purification, physicochemical, and kinetic properties of liver acetyl-CoA:arylamine N-acetyltransferase from rapid acetylator liver. Molecular Pharmacology 1987; 31: 446–456
- Blum M., Grant D.M., Demierre A., Meyer U.A. Nucleotide sequence of a full-length cDNA for arylamine N-acetyltransferase from rabbit liver. Nucleic Acids Research 1989a; 17: 3589
- Blum M., Grant D.M., Demierre A., Mayer U.A. N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits. Proceedings of the National Academy of Sciences, USA 1989b; 86: 9554–9557
- Blum M., Heim M., Meyer U.A. Nucleotide sequence of rabbit NAT1 encoding monomorphic arylamine N-acetyltransferase. Nucleic Acids Research 1990a; 18: 5287
- Blum M., Heim M., Meyer U.A. Nucleotide sequence of rabbit NAT2 encoding polymorphic liver arylamine N-acetyltransferase (NAT). Nucleic Acids Research 1990b; 18: 5295
- Blum M., Grant D.M., McBride O.W., Heim M., Meyer U.A. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization and functional expression. DNA Cell Biology 1990c; 9: 193–203
- Blum M., Demierre A., Grant D.M., Heim M., Meyer U.A. Molecular mechanism of slow acetylation of drugs and carcinogens in man. Proceedings of the National Academy of Sciences, USA 1991; 88: 5237–5241
- Bönicke R., Reif W. Enzymatic inactivation of isonicotinic acid hydrazide in humans and animals. Archives of Experimental Pathology and Pharmacology 1953; 220: 321–333
- Bönicke R., Lisboa B.P. On the inherited basis of intraindividual constancy of isoniazid elimination in man (studies of monozygotic and dizygotic twins). Naturwissenschaften 1957; 44: 314
- Deguchi T., Mashimo M., Suzuki T. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. Journal of Biological Chemistry 1990; 265: 12757–12760
- Drayer D.D., Reidenberg M.M. Clinical consequences of polymorphic acetylation of basic drugs. Clinical and Pharmacological Therapeutics 1977; 22: 251–258
- Dupret J.-M., Grant D.M. Involvement of Cys68 in the catalytic mechanism of polymorphic human arylamine N-acetyltransferase NAT2. FASEB Journal 1991; 5: A842
- Evans D. A. P., Manley K.A., McKusick V.A. Genetic control of isoniazid metabolism in man. British Medical Journal 1960; 2: 485–491
- Evans D. A. P., White T.A. Human acetylation polymorphism. Journal of Laboratory and Clinical Medicine 1964; 63: 394–403
- Evans D. A. P. N-acetyltransferase. Pharmacological Therapeutics 1989; 42: 157–234
- Glowinski I.B., Radtke H.E., Weber W.W. Genetic variation in N-acetylation of carcinogenic arylamines by human and rabbit liver. Molecular Pharmacology 1978; 14: 940–949
- Grant D.M., Tang B.K., Kalow W. A simple test for acetylator phenotype using caffeine. British Journal of Clinical Pharmacology 1984; 17: 459–464
- Grant D.M., Lottspeich F., Meyer U.A. Evidence for two closely related isozymes of arylamine N-acetyltransferase in human liver. FEBS Letters 1989a; 244: 203–207
- Grant D.M., Blum M., Demierre A., Meyer U.A. Nucleotide sequence of an intronless gene for a human arylamine N-acetyltransferase related to polymorphic drug acetylation. Nucleic Acids Research 1989b; 17: 3978
- Grant D.M., Mörike K., Eichelbaum M., Meyer U.A. Acetylation pharmacogenetics: the slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver. Journal of Clinical Investigation 1990; 85: 968–972
- Grant D.M., Blum M., Beer M., Meyer U.A. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Molecular Pharmacology 1991; 39: 184–191
- Grant D.M., Dupret J.-M. High-level expression of recombinant human arylamine N-acetyltransferases NAT1 and NAT2 in bacteria. FASEB Journal 1991; 5: A1205
- Jenne J.W. Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid. Journal of Clinical Investigation 1965; 44: 1992–2002
- Karim A. K. M. B., Elfellah M.S., Evans D. A. P. Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution. Journal of Medical Genetics 1981; 18: 325–330
- Ohsako S., Deguchi T. Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. Journal of Biological Chemistry 1990; 265: 4360–4634
- Ohsako S., Ohtomi M., Sakamoto Y., Uyemura K., Deguchi T. Arylamine N-acetyltransferase from chicken liver: II. Cloning of cDNA and expression in Chinese hamster ovary cells. Journal of Biological Chemistry 1988; 263: 7534–7538
- Weber W.W. The molecular basis of hereditary acetylation polymorphisms. Drug Metabolism and Disposition 1986; 14: 377–381
- Yamazoe Y., Abu-Zeid M., Ozawa S., Nagata K., Kato R. Genetic basis of N-acetylation polymorphism in hamster: purification of polymorphic and monomorphic isozymes and a nucleotide sequence of the monomorphic enzyme. Proceedings of the VIIIth International Symposium on Microsomes and Drug Oxidations,Stockholm,1990, 203